# Association between diabetes mellitus and impaired single-leg stance in patients with chronic liver disease: A cross-sectional study

**Authors:** Kenichi Fudeyasu, Makoto Asaeda, Toshihiro Kawae, Takuo Nomura, Yuki Nakashima, Daisuke Iwaki, Kouki Fukuhara, Takeya Araki, Haruya Ohno, Eisuke Murakami, Shiro Oka, Yukio Mikami, Bisher Sawaf, Rafael Oliveira, Rafael Oliveira, Rafael Oliveira

PMC · DOI: 10.1371/journal.pone.0345407 · PLOS One · 2026-03-24

## TL;DR

This study finds that diabetes is linked to worse balance in patients with chronic liver disease, with body water ratios and age being key predictors.

## Contribution

The study identifies a novel association between diabetes and impaired balance in chronic liver disease patients, highlighting the predictive role of body water ratios.

## Key findings

- Diabetic patients with chronic liver disease had significantly worse single-leg stance test results compared to non-diabetic patients.
- Age, body mass index, and extracellular water-to-total body water ratio were significant predictors of impaired balance.
- An extracellular water-to-total body water ratio of 0.393 best predicted impaired balance, indicating subclinical edema.

## Abstract

Diabetes mellitus (DM) is highly prevalent among patients with chronic liver disease (CLD) and is associated with disease progression and complications. However, the impact of DM on physical function, particularly balance, in patients with CLD remains unclear. The aim of this study was to investigate the association between DM and physical function in patients with CLD, with a specific focus on impaired single-leg stance test (SLST). This retrospective study analyzed the medical records of patients with CLD at Hiroshima University Hospital between 2014 and 2017. Logistic regression analysis was performed to identify factors associated with impaired SLST. Receiver operating characteristic curve analysis was conducted to determine cutoff values for predictive factors. The analysis included 152 patients with CLD, of whom 78% had comorbid DM. Patients with DM had a significantly higher prevalence of impaired SLST than those without DM (20% vs. 0%, p = 0.002, Cramer’s V 0.23). In 118 patients with CLD who had comorbid DM, age (odds ratio [OR] 1.089, 95% confidence interval [CI] 1.020–1.177, p = 0.009), body mass index (OR 1.176, 95% CI 1.045–1.343, p = 0.006), and extracellular water-to-total body water ratio (ECW/TBW) (OR 1.065, 95% CI 1.003–1.138, p = 0.039) were significant independent factors associated with impaired SLST (Nagelkerke pseudo-R² 0.31, p < 0.001). The ECW/TBW had the highest predictive accuracy, with a cutoff value of 0.393 (area under the curve = 0.733, sensitivity = 73.9%, specificity = 68.8%). DM was associated with impaired SLST in patients with CLD, suggesting a decline in balance. Age, body mass index, and ECW/TBW are significant predictors of impaired SLST. An ECW/TBW ratio of 0.393 indicates “subclinical” edema in patients with CLD and DM and should be considered in the assessment of fall risk.

## Linked entities

- **Diseases:** Diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, MSTN (myostatin) [NCBI Gene 2660] {aka GDF8, MSLHP}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** end-stage liver disease (MESH:D058625), Child-Pugh A (MESH:C562515), AWGS (MESH:D055948), diabetic peripheral neuropathy (MESH:D010523), type 2 DM (MESH:D003924), ACADEMIC EDITOR (MESH:D007859), obesity (MESH:D009765), nonalcoholic fatty liver disease (MESH:D065626), Weight loss (MESH:D015431), falls (MESH:C537863), peritonitis (MESH:D010538), Cirrhosis (MESH:D005355), chronic hepatitis (MESH:D006521), locomotive syndrome (MESH:D020233), decreased muscle strength (MESH:D009123), SMI (MESH:C536030), ascites (MESH:D001201), dyslipidemia (MESH:D050171), muscle dysfunction (MESH:D009135), variceal bleeding (MESH:D014648), neuromuscular diseases (MESH:D009468), insulin resistance (MESH:D007333), dementia (MESH:D003704), proprioceptive impairment (MESH:D020886), balance impairment (MESH:D060825), hyperammonemia (MESH:D022124), ALD (MESH:D008108), fluid retention (MESH:D016055), metabolic dysfunction (MESH:D008659), SLST (MESH:D013736), edema (MESH:D004487), Liver fibrosis (MESH:D008103), neuropathy (MESH:D009422), DM (MESH:D003920), impaired single-leg stance (MESH:D012640), Impaired gait (MESH:D020234), musculoskeletal or neuromuscular disorders (MESH:D009139), hypoglycemia (MESH:D007003), DL (MESH:C537113), hepatic encephalopathy (MESH:D006501), HT (MESH:D006973), impaired glucose tolerance (MESH:D018149), CLD (MESH:D008107), pain (MESH:D010146), cirrhotic (MESH:D000094724), muscle (MESH:D019042), muscle weakness (MESH:D018908), liver dysfunction (MESH:D017093), -related impairment (MESH:D000084202), HCC (MESH:D006528), portal hypertension (MESH:D006975), muscle atrophy (MESH:D009133), lymphatic dysfunction (MESH:D008206), overhydrated (MESH:D014869), Diabetic Neuropathy (MESH:D003929)
- **Chemicals:** bilirubin (MESH:D001663), TG (MESH:D013866), Bisher (-), uric acid (MESH:D014527), triglycerides (MESH:D014280), water (MESH:D014867), NH3 (MESH:D000641)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], hepatitis C virus [taxon 11103], Homo sapiens (human, species) [taxon 9606], Hepatitis B virus (no rank) [taxon 10407]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012516/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012516/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012516/full.md

---
Source: https://tomesphere.com/paper/PMC13012516